GlassScriptPhysician profile
Dwan S Mabry
NPI 1104822782
$3,310.15
in general payments reported to CMS, 2019-2025
44 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $124 · 2021: $551 · 2022: $873 · 2023: $392 · 2024: $289 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.56 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $641.89 | 2019-2023 | |
| Exeltis, USA INC. | $329.26 | 2019-2025 | Slynd |
| Cumberland Pharmaceuticals, INC. | $311.16 | 2019-2024 | Caldolor |
| Avion Pharmaceuticals | $204.90 | 2021-2023 | Balcoltra |
| Astellas Pharma US INC | $111.17 | 2023-2025 | Veozah |
| Pfizer INC. | $107.48 | 2021-2024 | |
| Medtronic, INC. | $105.65 | 2025 | Truclear |
| Organon LLC | $103.20 | 2021-2025 | Jada System, Nexplanon |
| Mylan Pharmaceuticals INC. | $102.22 | 2019-2022 | |
| Scynexis, INC. | $101.12 | 2022 | |
| Avanos Medical | $100.58 | 2019 | |
| Amgen INC. | $91.66 | 2019-2022 | |
| Caldera Medical, INC | $91.09 | 2021 | |
| Hologic Sales and Service, LLC | $79.83 | 2019-2024 | Aptima |
| Aspira Women'S Health INC | $74.80 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwan Mabry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.